October 30, 2026 Quectel Sues Telit, Alleging False Statements, Cybersquatting and Unfair Competition
October 30, 2026 Darwin Biotech Presented Randomized Phase 1 ALS Study Data of Cell-Free ALT001 and U.S. Phase 1/2 Study Design at 2026 NEALS Annual Meeting
All HIV medicines on these platforms should be considered suspect products
All HIV medicines on these platforms should be considered suspect products 
